# Daiichi Sankyo Europe GmbH – FDA Inspection, Jul 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/02cc4ef0-7e2f-4314-a0e8-7193ad8f6f8f
Source feed: FDA_Inspections

> FDA inspection 1275919 of Daiichi Sankyo Europe GmbH, July 18, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275919
- Company Name: Daiichi Sankyo Europe GmbH
- Inspection Date: 2025-07-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- FDA Inspection 1073797 - 2018-10-19
- FDA Inspection 1019118 - 2017-06-09
- FDA Inspection 882156 - 2014-05-15
- FDA Inspection 802508 - 2012-09-20
- FDA Inspection 649526 - 2010-01-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)

Company: https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8